Effective March 1, 2016, PathGroup will offer Informed Pregnancy Screen, a non-invasive prenatal screen (NIPS) that analyzes cell-free DNA (cfDNA) using next-generation sequencing to determine if a pregnancy is at increased risk for certain chromosome aneuploidies. Informed Pregnancy Screen has an industry-leading ‘no-call’ rate of 0.1% and a personalized positive predictive value (PPV) is included on every positive result. The test can be performed as early as 10 weeks gestation and results will be available in approximately 1 week. Electronic ordering and results delivery is available to PathGroup clients and post-test genetic counseling is available to patients if desired.
Click Here to read more.